Avanir Reports Positive Trial Results
Avanir Pharmaceuticals (AVNR) shares leaped $3.92 to close at $5.19 after reporting positive results for its diabetic pain drug.
posted by FC Market News at 9:29 AM
Wednesday, April 18, 2007
Previous Posts
- JP Morgan Reports Higher Earnings
- Solarfun Power Downgraded
- TD Ameritrade Falls Short
- BCE Confirms Sale Rumors
- Telik Reports Positive Drug Trial Results
- Possible Client Losses Send First Marblehead Lower
- AK Steel Named One Of Best Investments Of 2006
- Potential Buyer For Fremont General Subprime Business
- Quest Diagnostics To Acquire AmeriPath
- Apollo Investment To Buy Innkeepers USA
0 Comments:
Post a Comment
<< Home